MICHAEL V MACRI

Allopathic & Osteopathic Physicians|Family Medicine WESTWOOD, NJ NPI 1497864052

General Payments — all program years on this page

$320.02

  • Category: General Payments
  • Program years: PY2018–2019
  • Record count: 24
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $185.58 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $185.5813

By paying entity

Latest program year (PY2019) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $67.915
Novo Nordisk AS $40.733
GlaxoSmithKline, LLC. $28.862
SANOFI-AVENTIS U.S. LLC $21.451
Allergan Inc. $14.831
Teva Pharmaceuticals USA, Inc. $11.801

By program year

Program yearAmountRecords
2018 $134.4411
2019 $185.5813

Records — PY2019 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
668769707 Novo Nordisk Inc $14.35 01/15/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
669478407 Novo Nordisk Inc $14.99 03/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
670753517 Allergan Inc. $14.83 06/04/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
670768623 GlaxoSmithKline, LLC. $13.92 03/13/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671245681 GlaxoSmithKline, LLC. $14.94 07/02/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
674485797 Novo Nordisk Inc $11.39 07/15/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685090769 AstraZeneca Pharmaceuticals LP $12.64 07/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685104819 AstraZeneca Pharmaceuticals LP $13.54 11/04/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685308209 AstraZeneca Pharmaceuticals LP $13.01 10/17/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685327231 AstraZeneca Pharmaceuticals LP $15.22 12/09/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685378445 AstraZeneca Pharmaceuticals LP $13.50 09/16/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
694259277 SANOFI-AVENTIS U.S. LLC $21.45 11/25/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
697690761 Teva Pharmaceuticals USA, Inc. $11.80 03/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.